We are back with lots of OncoPharm updates:
1. The belantamab mafodotin REMS program details are available....and it's a lot.
How will belantamab mafodin-regimens be used with the upcoming MAJESTIC-3 data of teclistamab-daratumumab?
2. The capecitabine label is updated and calls for pre-treatment DPYD testing
3. Daratumumab gets an FDA approval for high-r ... Show More
Jun 2021
Review Series on Platelets and Cancer
Platelets are critical for hemostasis and thrombosis, but recent research highlights their role in many other processes, including inflammation, wound healing, and lymphangiogenesis. In this episode, Drs. José López, Elisabeth Battinelli, Craig Williams, and Owen McCarty discuss ... Show More
35m 27s
Oct 15
NEJM This Week — October 16, 2025
In this episode, we look at new research in cervical cancer, lupus, gene therapy for immune deficiency, and malaria prevention in infants. We review hair loss in women, follow a case of tuberculosis in advanced HIV, and hear perspectives on vaccines, primary care, digital health, ... Show More
30m 33s
Sep 8
Marsquakes, Vaccine Politics and Mammoth Microbiomes
This week’s roundup dives into Mars’s lumpy mantle, a nasal spray that may help prevent COVID and the growing confusion around vaccine access in the U.S. Plus, researchers link phone use while on the toilet to hemorrhoid risk, uncover ancient mammoth microbiomes and explain why s ... Show More
9m 45s
<p>In this episode, we review the high-yield topic of <a href="https://step2.medbullets.com/oncology/120467/acute-lymphoblastic-leukemia-all">Acute Lymphoblastic Leukemia (ALL)</a> from the Oncology section.</p>
<p>Follow <a href="https://step1.medbullets.com/">Medbullets</a> on ... Show More
